IBDEI1QF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30642,0)
 ;;=N70.03^^178^1924^13
 ;;^UTILITY(U,$J,358.3,30642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30642,1,3,0)
 ;;=3^Acute salpingitis and oophoritis
 ;;^UTILITY(U,$J,358.3,30642,1,4,0)
 ;;=4^N70.03
 ;;^UTILITY(U,$J,358.3,30642,2)
 ;;=^270465
 ;;^UTILITY(U,$J,358.3,30643,0)
 ;;=N70.11^^178^1924^30
 ;;^UTILITY(U,$J,358.3,30643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30643,1,3,0)
 ;;=3^Chronic salpingitis
 ;;^UTILITY(U,$J,358.3,30643,1,4,0)
 ;;=4^N70.11
 ;;^UTILITY(U,$J,358.3,30643,2)
 ;;=^5015804
 ;;^UTILITY(U,$J,358.3,30644,0)
 ;;=N70.12^^178^1924^29
 ;;^UTILITY(U,$J,358.3,30644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30644,1,3,0)
 ;;=3^Chronic oophoritis
 ;;^UTILITY(U,$J,358.3,30644,1,4,0)
 ;;=4^N70.12
 ;;^UTILITY(U,$J,358.3,30644,2)
 ;;=^5015805
 ;;^UTILITY(U,$J,358.3,30645,0)
 ;;=N70.13^^178^1924^31
 ;;^UTILITY(U,$J,358.3,30645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30645,1,3,0)
 ;;=3^Chronic salpingitis and oophoritis
 ;;^UTILITY(U,$J,358.3,30645,1,4,0)
 ;;=4^N70.13
 ;;^UTILITY(U,$J,358.3,30645,2)
 ;;=^270466
 ;;^UTILITY(U,$J,358.3,30646,0)
 ;;=N73.9^^178^1924^53
 ;;^UTILITY(U,$J,358.3,30646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30646,1,3,0)
 ;;=3^Female pelvic inflammatory disease, unspecified
 ;;^UTILITY(U,$J,358.3,30646,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,30646,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,30647,0)
 ;;=N72.^^178^1924^59
 ;;^UTILITY(U,$J,358.3,30647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30647,1,3,0)
 ;;=3^Inflammatory disease of cervix uteri
 ;;^UTILITY(U,$J,358.3,30647,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,30647,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,30648,0)
 ;;=N76.0^^178^1924^14
 ;;^UTILITY(U,$J,358.3,30648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30648,1,3,0)
 ;;=3^Acute vaginitis
 ;;^UTILITY(U,$J,358.3,30648,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,30648,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,30649,0)
 ;;=N76.1^^178^1924^95
 ;;^UTILITY(U,$J,358.3,30649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30649,1,3,0)
 ;;=3^Subacute and chronic vaginitis
 ;;^UTILITY(U,$J,358.3,30649,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,30649,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,30650,0)
 ;;=N75.0^^178^1924^34
 ;;^UTILITY(U,$J,358.3,30650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30650,1,3,0)
 ;;=3^Cyst of Bartholin's gland
 ;;^UTILITY(U,$J,358.3,30650,1,4,0)
 ;;=4^N75.0
 ;;^UTILITY(U,$J,358.3,30650,2)
 ;;=^5015822
 ;;^UTILITY(U,$J,358.3,30651,0)
 ;;=N75.1^^178^1924^5
 ;;^UTILITY(U,$J,358.3,30651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30651,1,3,0)
 ;;=3^Abscess of Bartholin's gland
 ;;^UTILITY(U,$J,358.3,30651,1,4,0)
 ;;=4^N75.1
 ;;^UTILITY(U,$J,358.3,30651,2)
 ;;=^5015823
 ;;^UTILITY(U,$J,358.3,30652,0)
 ;;=N76.4^^178^1924^6
 ;;^UTILITY(U,$J,358.3,30652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30652,1,3,0)
 ;;=3^Abscess of vulva
 ;;^UTILITY(U,$J,358.3,30652,1,4,0)
 ;;=4^N76.4
 ;;^UTILITY(U,$J,358.3,30652,2)
 ;;=^5015830
 ;;^UTILITY(U,$J,358.3,30653,0)
 ;;=N80.0^^178^1924^46
 ;;^UTILITY(U,$J,358.3,30653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30653,1,3,0)
 ;;=3^Endometriosis of uterus
 ;;^UTILITY(U,$J,358.3,30653,1,4,0)
 ;;=4^N80.0
 ;;^UTILITY(U,$J,358.3,30653,2)
 ;;=^270482
 ;;^UTILITY(U,$J,358.3,30654,0)
 ;;=N80.1^^178^1924^45
 ;;^UTILITY(U,$J,358.3,30654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30654,1,3,0)
 ;;=3^Endometriosis of ovary
 ;;^UTILITY(U,$J,358.3,30654,1,4,0)
 ;;=4^N80.1
 ;;^UTILITY(U,$J,358.3,30654,2)
 ;;=^270484
 ;;^UTILITY(U,$J,358.3,30655,0)
 ;;=N81.11^^178^1924^35
 ;;^UTILITY(U,$J,358.3,30655,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1QF
